Other venture-backed companies like Chai Discovery and Isomorphic Labs have raced to build better models. SandboxAQ is ...
Researchers developing autonomous artificial intelligence research tools say that they’ll soon be able to integrate with lab ...
Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it ...
Ultra-Fast Protein/Antibody Synthesis in 3 Hours, Speed Up AI-Powered HTP Screening HOUSTON, TEXAS - May 18, 2026 ...
A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major ...
When Daniel Haders, Ph.D., was working in venture capital, he was on the hunt for an AI-driven drug discovery company that ...
Anthropic teams up with Eric Schmidt-backed SandboxAQ to bring AI-powered drug discovery tools to researchers, raising hopes ...
Since announcing a transformational $250 million partnership in May 2025, Purdue University and Eli Lilly and Company have ...
Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is ...
Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...
Hit identification and hit validation represent distinct but connected stages of early drug discovery. This article examines how HTS, hit triage, and validation assays reduce false positives and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results